Venture capital firm Dynamk Capital LLC, which invests in early-stage life sciences companies, added Gustavo Mahler as a venture partner.
Previously, Mahler was the CEO of AGC Biologics.
Discover more about S&P Global’s offerings
Dynamk Capital adds venture partner
Street Talk | Episode 94: Recessionary fears in ’22 overblown, Fed could overtighten
Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds
Investment Banking Essentials Newsletter April Edition - 2022
Banking Essentials Newsletter April Edition - 2022
Venture capital firm Dynamk Capital LLC, which invests in early-stage life sciences companies, added Gustavo Mahler as a venture partner.
Previously, Mahler was the CEO of AGC Biologics.